Nicholas Wald studied medicine at University College, London. He is currently Honorary Professor of Preventive Medicine, Institute of Health Informatics, University College London. He was Professor of Environmental and Preventive Medicine at the Wolfson Institute of Preventive Medicine from 1983 to 2019, and is Editor of the Journal of Medical Screening. He has conducted research in many areas including birth defects, cardiovascular disease, cancer, and the health effects of smoking and nutrition.
Malcolm Law studied medicine at the University of Adelaide, Australia. He is Professor of Epidemiology and Preventive Medicine at the Wolfson Institute of Preventive Medicine at St Bartholomew’s and the Royal London School of Medicine and is Associate Editor for the Journal of Medical Screening. His research interests include the causes of coronary heart disease and stroke, and their prevention.
David Wald studied medicine at Oxford and St. Mary‘s Hospital Medical School in London. He is Professor of Cardiology and Honorary Consultant Cardiologist at the Wolfson Institute of Preventive Medicine at St Bartholomew’s and the Royal London School of Medicine. His clinical-academic aims are to bridge the interventional and preventive approaches to cardiovascular disease which are often viewed as distinct.
Jeff Aronson studied medicine at Glasgow University. He is Reader in Clinical Pharmacology in the University of Oxford, an Honorary Consultant Physician at the Oxford University Radcliffe NHS Trust, and President Emeritus of the British Pharmacological Society. His research interests span all aspects of drug therapy, particularly adverse drug reactions and monitoring responses to therapeutic interventions.
John Dickinson studied physiology at Oxford and medicine at University College, London. He was Emeritus Professor of Medicine at the Wolfson Institute of Preventive Medicine at St Bartholomew’s and the Royal London School of Medicine, and served as Chairman of the British Medical Research Council and Senior Vice-President of the Royal College of Physicians. He published on several medical fields, notably human high blood pressure. John Dickinson died in September 2015.
Karen Wald studied philosophy, politics and economics at Somerville College, Oxford. She is Director of Logical Medical Systems, a company that produces antenatal screening for Down syndrome. She has worked with Professor Eva Alberman in the assessment of congenital mental childhood handicap in the United Kingdom.
Fatima Bangash qualified in medicine at Rawalpindi Medical College in Pakistan and obtained the MSc Epidemiology from the London School of Hygiene and Tropical Medicine, London, UK. She is registered and licensed to practice medicine from the General Medical Council. She is a core medical trainee at Barts Health NHS Trust and an honorary research fellow at the Wolfson Institute of Preventive Medicine. Her ambition is to deliver advances in the prevention and treatment of cardiovascular disease, and to conduct research in both areas.
Our doctors and website team are on hand to guide you through the Polypill Prevention Programme. The best way to contact a member of the team is to send us a message via your online account.
Dr Bangash is supported by Professors Nicholas and David Wald.
Our doctors are registered with the General Medical Council - the independent regulator for doctors in the UK. This helps to protect, promote and maintain the health and safety of the public by ensuring proper standards of the general practitioners within our practice.
Dr Fatima Bangash: 7067360
Professor Nicholas Wald: 0781503
Professor David Wald: 4049070
Polypill.com is a site operated by Polypill Limited. Polypill Limited is registered in England and Wales under company number 04301974. The registered office and the main trading address is 71 Queen Victoria Street, London, EC4V 4BE
The medicine is dispensed and posted from IPS Specials (Vertical Pharma Resources Limited, 41 Central Avenue, West Molesey, Surrey, United, Kingdom, KT8 2QZ) by Royal Mail First Class. IPS Specials is registered with the General Pharmaceutical Council (GPhC) with number 1103485
Feedback, suggestions and complaints can be made by sending a message from your electronic patient record. Complaints should normally be acknowledged within 72 hours and responded to in full within two weeks.